Marex Group investors report 0% beneficial ownership
Marex Group plc is the issuer of Common Stock with a par value of $0.001551 per share, identified by CUSIP G5S37H101.
Rhea-AI Filing Summary
Marex Group plc is the issuer of Common Stock with a par value of $0.001551 per share, identified by CUSIP G5S37H101. This Schedule 13G/A (Amendment No. 2) is filed by MASP Investor Limited Partnership, its general partner Forty Two Point Two Acquisition Limited, and BXR Group Holdings Limited.
The reporting group states that, as of the reporting date, Forty Two Point Two Acquisition Limited directly holds 0 shares of Marex Group plc, and each reporting person has 0 shares beneficially owned, representing 0% of the outstanding common stock. They report no sole or shared voting power and no sole or shared dispositive power over Marex Group plc shares, indicating that they now own 5 percent or less of this class of securities.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficial ownership financial
Sole Voting Power financial
Dispositive Power financial
Schedule 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does this Schedule 13G/A filing mean for Marex Group plc (MRX)?
Who are the reporting persons in this Marex Group plc (MRX) Schedule 13G/A?
What is the class of securities covered in this Marex Group plc (MRX) Schedule 13G/A?
Why does the Marex Group plc (MRX) Schedule 13G/A mention ownership of 5 percent or less?
AI-generated analysis. How Rhea-AI works. Not financial advice.